Free Trial

TELA Bio (TELA) Stock Price, News & Analysis

-0.34 (-6.75%)
(As of 01:53 PM ET)
Today's Range
50-Day Range
52-Week Range
88,909 shs
Average Volume
174,024 shs
Market Capitalization
$115.90 million
P/E Ratio
Dividend Yield
Price Target

TELA Bio MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
166.4% Upside
$13.00 Price Target
Short Interest
3.88% of Shares Sold Short
Dividend Strength
News Sentiment
Insider Trading
Selling Shares
$1.86 M Sold Last Quarter
Proj. Earnings Growth
From ($1.49) to ($1.17) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.38 out of 5 stars

Medical Sector

513th out of 912 stocks

Surgical & Medical Instruments Industry

60th out of 100 stocks

TELA stock logo

About TELA Bio Stock (NASDAQ:TELA)

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

TELA Stock Price History

TELA Stock News Headlines

This is HOW many elite traders think
Want a preview of how elite traders think?! For a limited time, you can claim AI SMS alerts from TradeAlgo for FREE.
This is HOW many elite traders think
Want a preview of how elite traders think?! For a limited time, you can claim AI SMS alerts from TradeAlgo for FREE.
Lake Street Reaffirms Their Buy Rating on TELA Bio (TELA)
See More Headlines
Receive TELA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TELA Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$58.45 million
Book Value
$0.77 per share


Free Float
Market Cap
$120.34 million
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Antony Koblish (Age 58)
    Co-founder, President, CEO & Director
    Comp: $1.03M
  • Mr. Roberto E. Cuca J.D. (Age 56)
    CFO & COO
    Comp: $674.78k
  • Mr. Paul Talmo (Age 52)
    Chief Technology Officer
    Comp: $595.67k
  • Ms. Megan Smeykal (Age 48)
    VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer
  • Mr. D. Taylor Ocasio
    General Counsel & Corporate Secretary
  • Ms. Jennifer Lou Armstrong (Age 54)
    Senior Vice President of Human Resources
  • Mr. Gregory A. Firestone (Age 65)
    Chief Commercial Officer
  • Mr. Michael Leonard
    Senior Vice President of Technical Operations
  • Mr. Peter C. Murphy (Age 51)
    Chief Commercial Officer
    Comp: $542.34k
  • Louisa Smith
    Investor Relations Contact Officer

TELA Stock Analysis - Frequently Asked Questions

How have TELA shares performed this year?

TELA Bio's stock was trading at $6.62 at the beginning of 2024. Since then, TELA shares have decreased by 26.3% and is now trading at $4.88.
View the best growth stocks for 2024 here

How were TELA Bio's earnings last quarter?

TELA Bio, Inc. (NASDAQ:TELA) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.48) by $0.25. The business earned $16.60 million during the quarter, compared to analyst estimates of $15.90 million. TELA Bio had a negative trailing twelve-month return on equity of 155.26% and a negative net margin of 63.82%.

When did TELA Bio IPO?

TELA Bio (TELA) raised $60 million in an initial public offering (IPO) on Friday, November 8th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. Jefferies and Piper Jaffray acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

How do I buy shares of TELA Bio?

Shares of TELA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of TELA Bio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that TELA Bio investors own include Micron Technology (MU), Intel (INTC), Pfizer (PFE), CrowdStrike (CRWD), Walt Disney (DIS), Gilead Sciences (GILD) and Inovio Pharmaceuticals (INO).

This page (NASDAQ:TELA) was last updated on 7/15/2024 by Staff

From Our Partners